STEVE TIU: Open Payments
NPI 1457841090 · POMONA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,249 in 319 payments from 33 companies in 2025. Trend: 2023 $2,739 · 2024 $4,719 · 2025 $5,249
Food & beverage: $5,249
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 65 | $909 |
| UCB, Inc. | 24 | $557 |
| ACADIA Pharmaceuticals Inc | 26 | $374 |
| Alexion Pharmaceuticals, Inc. | 11 | $304 |
| SK Life Science, Inc. | 23 | $298 |
| Biogen, Inc. | 15 | $295 |
| Lundbeck LLC | 16 | $265 |
| Novartis Pharmaceuticals Corporation | 27 | $252 |
| Neurocrine BioSciences, Inc. | 8 | $234 |
| PFIZER INC. | 17 | $219 |
Products named: QULIPTA, Rystiggo, NUPLAZID, ULTOMIRIS, VYEPTI, KESIMPTA, INGREZZA, NURTEC ODT.
Industry payments across CA — which companies pay providers there.
